Speakers

Andreas Kuhn, Ph.D.

Vice President RNA Biochemistry & Manufacturing

BioNTech RNA Pharmaceuticals GmbH

Prof. Catherine Green

Associate Professor, Head of Clinical Biomanufacturing Facility

University of Oxford

David K. Robinson, Ph.D.

Deputy Director, CMC Vaccines Development & Surveillance

Bill and Melinda Gates Foundation

Kelvin Lee, Ph.D.

Institute Director

NIIMBL

Parastoo Azadi, Ph.D.

Technical Director, Complex Carbohydrate Research Center

University of Georgia

Anissa Boumlic-Courtade

Head of Global Vaccine & Plasma Segments, Bioprocessing

Merck

Nandu Deorkar

Vice President

Avantor

Thomas Goldsby, Ph.D.

Professor, Supply Chain Management, Global Supply Chain Institute

Haslam College of Business, University of Tennessee

Robert Gronke, PhD

Senior Principal Scientist, Technical Development

Biogen, Inc

Tomoko Hongo-Hirasaki, Ph.D

Lead Expert, Scientific Affairs, Global Marketing, Bioprocess Division

Asahi Kasei Medical Co., Ltd.

Jeffrey Hung

Chief Commercial Officer

Vigene Biosciences, Inc., USA

Satish Ravetkar, Ph.D.

Executive Director

Serum Institute of India Pvt Ltd.

Nadine Ritter, Ph.D.

President and Analytical Advisor

Global Biotech Experts, LLC

Joerge Schwinde

Key Segment Manager

Eppendorf AG

Dan Spacie

Chief Executive Officer

BioPhorum

Ralf Wagner

Head Section Viral Vaccines

Paul-Ehrlich-Institut

Ashleigh Wake

Business Development Director

Intertek Pharmaceutical Services

Bruce Yu

Professor

Maryland University

Aleš Štrancar

Managing Director

BIA Separations